drugset / Trial / NCT04971031
A Clinical Trial to Assess Subjects With Dry Eye Disease.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Multi-Center Randomized, Double-Masked, Parallel Design, Vehicle-Controlled Phase 2 Clinical Trial to Assess the Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease
Timeline
- Start
- 2021-06-15
- Primary completion
- 2021-09-08
- Completion
- 2021-09-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Reproxalap | Other / unclassified | 0.25 % | Other |